Determination of Mercapto Groups in Human Hair Treated with Chlorine Oxides
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Whole Grain Processing, Funcqonal Components for Posiqve Food
Whole Grain Processing, Func3onal Components for Posi3ve Food A<ributes and Health Eric A. Decker Department of Food Science University of Massachuse<s How We Decide What Food to Buy? Nutri3on Convenience Value Taste Convenience Time Management • 1887: Half of a households labor hours were for preparing foods • 2010: – Food preparaon < 25 min/day www.d.umn.edu www.businessinsider.com Convenience Time Management • Households are also spending less 3me shopping for foods (< 15 min/day) – Requires foods will long shelf-life so food shopping is not a daily event – Requires one stop shopping vs. individual food vendors www.ers.usda.gov www.getrealmaine.com Value Increased Spending Power • Food Cost are declining 30 23.4% in 1929 25 20 15 10 9.6% in 2008 % Di sp o5 sab l e I n co me 0 1920 1940 1960 1980 2000 2020 Year Whole Grains and Value www.mlive.com www.namamillers.org Whole Wheat Flour • Typically made by recombining the bran, germ and white flour at proper propor3ons • Straight grinding of the wheat berry can cause breaking of the germ and spreading of the germ oil throughout the flour • Germ Oil – 83% linoleic acid (18:2; omega 6) – 7% linolenic acid (18:3; omega 3) Impact of Unsaturation on Susceptibility to Lipid Oxidation RELATIVE OXIDIZIBILITY 1 18:1 10 18:2 20 18:3 30 20:4 40 20:5 Newspapers soaked in linseed oil caused fire due to spontaneous combus3on (Hampshire Gaze<e; Northampton, MA) Value Why are Whole Grain Flour and Products More Expensive? • Shelf-life – Whole wheat flour has a limited shelf-life due to rancidity = 1-3 months -
CDG Solution 3000TM Safety Data Sheet
Emergency Telephone Number: 800-424-9300 24 hours/day, 7 days/week Emergency Telephone Number: 800-424-9300 24 hours, 7 days/week CDG Solution 3000TM Safety Data Sheet Section 1 – Chemical Product and Company Identification Product Identifier: Chlorine Dioxide 0.3% Aqueous Solution SDS No. CD-004 Other Means of Identification: Chlorine Oxide Solution Chlorine Peroxide Solution Chlorine (IV) Oxide Solution Chloroperoxyl Solution Recommended Use: Biocide Company: CDG Environmental, LLC 301 Broadway, Suite 420 Bethlehem, PA 18015 888-610-2562 484-821-0780 Emergency Phone Number: 800-424-9300 SDS # CD-004 CDG Solution 3000 Page 1 of 12 Emergency Telephone Number: 800-424-9300 24 hours, 7 days/week Section 2 – Hazards Identification GHS Classification: Skin Irritation: Category 2 Eye Irritation: Category 2B Acute Toxicity – Inhalation: Category 4 Signal Word: Warning Pictogram: Hazard Statements: Causes skin irritation Causes eye irritation Harmful in inhaled Precautionary Wash exposed areas thoroughly after handling. Statements: Wear protective gloves. Avoid breathing fume/gas/mist/vapors/spray. Use only outdoors or in a well-ventilated area. If on skin: Wash with plenty of water. If skin irritation occurs: Get medical attention. If in eyes: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical attention. If inhaled: Remove person to fresh air and keep comfortable for breathing. Call a doctor if you feel unwell. Specific treatment (see First -
Toxicological Profile for Chlorine Dioxide and Chlorite
TOXICOLOGICAL PROFILE FOR CHLORINE DIOXIDE AND CHLORITE U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry September 2004 CHLORINE DIOXIDE AND CHLORITE ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. CHLORINE DIOXIDE AND CHLORITE iii UPDATE STATEMENT Toxicological Profile for Chlorine Dioxide and Chlorite, Draft for Public Comment was released in September 2002. This edition supersedes any previously released draft or final profile. Toxicological profiles are revised and republished as necessary. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology/Toxicology Information Branch 1600 Clifton Road NE, Mailstop F-32 Atlanta, Georgia 30333 CHLORINE DIOXIDE AND CHLORITE vi *Legislative Background The toxicological profiles are developed in response to the Superfund Amendments and Reauthorization Act (SARA) of 1986 (Public law 99-499) which amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund). This public law directed ATSDR to prepare toxicological profiles for hazardous substances most commonly found at facilities on the CERCLA National Priorities List and that pose the most significant potential threat to human health, as determined by ATSDR and the EPA. The availability of the revised priority list of 275 hazardous substances was announced in the Federal Register on November 17, 1997 (62 FR 61332). For prior versions of the list of substances, see Federal Register notices dated April 29, 1996 (61 FR 18744); April 17, 1987 (52 FR 12866); October 20, 1988 (53 FR 41280); October 26, 1989 (54 FR 43619); October 17, 1990 (55 FR 42067); October 17, 1991 (56 FR 52166); October 28, 1992 (57 FR 48801); and February 28, 1994 (59 FR 9486). -
Cysteine, Glutathione, and Thiol Redox Balance in Astrocytes
antioxidants Review Cysteine, Glutathione, and Thiol Redox Balance in Astrocytes Gethin J. McBean School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland; [email protected]; Tel.: +353-1-716-6770 Received: 13 July 2017; Accepted: 1 August 2017; Published: 3 August 2017 Abstract: This review discusses the current understanding of cysteine and glutathione redox balance in astrocytes. Particular emphasis is placed on the impact of oxidative stress and astrocyte activation on pathways that provide cysteine as a precursor for glutathione. The effect of the disruption of thiol-containing amino acid metabolism on the antioxidant capacity of astrocytes is also discussed. − Keywords: cysteine; cystine; cysteamine; cystathionine; glutathione; xc cystine-glutamate exchanger; transsulfuration 1. Introduction Thiol groups, whether contained within small molecules, peptides, or proteins, are highly reactive and prone to spontaneous oxidation. Free cysteine readily oxidises to its corresponding disulfide, cystine, that together form the cysteine/cystine redox couple. Similarly, the tripeptide glutathione (γ-glutamyl-cysteinyl-glycine) exists in both reduced (GSH) and oxidised (glutathione disulfide; GSSG) forms, depending on the oxidation state of the sulfur atom on the cysteine residue. In the case of proteins, the free sulfhydryl group on cysteines can adopt a number of oxidation states, ranging from disulfides (–S–S–) and sulfenic acids (–SOOH), which are reversible, to the more oxidised sulfinic (–SOO2H) and sulfonic acids (–SOO3H), which are not. These latter species may arise as a result of chronic and/or severe oxidative stress, and generally indicate a loss of function of irreversibly oxidised proteins. Methionine residues oxidise to the corresponding sulfoxide, which can be rescued enzymatically by methionine sulfoxide reductase [1]. -
Heterogeneous Production of Perchlorate and Chlorate By
HETEROGENEOUS PRODUCTION OF PERCHLORATE AND CHLORATE BY OZONE OXIDATION OF Cl- by SIXUAN WANG B.E. A Thesis In CIVIL ENGINEERING Submitted to the Graduate Faculty of Texas Tech University in Partial Fulfillment of The Requirements for The Degree of MASTER OF SCIENCE IN CIVIL ENGINEERING Approved Dr. Andrew W. Jackson Chairperson of the Committee Dr. Todd A. Anderson Peggy Gordon Dean of Graduate School August, 2011 Copyright © 2011, Sixuan Wang Texas Tech University, Sixuan Wang, August 2011 ACKNOWLEDGEMENTS This research project would not finish without the support of many people. I would like to express my gratitude to all those who gave me help and support to complete this thesis. I want to thank Dr. Andrew Jackson, the chair of my committee for giving me the chance, guidance, and encouragement. I would like to take this opportunity to thank my committee members, Dr. Todd Anderson, for his continuous support and encouragement all the way. I would also take this opportunity to thank my friends and colleagues Dr. Rao, Nubia, Felipe, Tony and Tim for their continuous help, sharing during these two years of research in Environmental lab. I am very thankful to the Strategic Environmental Research and Development Program (SERDP) for providing the necessary funds for this project. ii Texas Tech University, Sixuan Wang, August 2011 TABLE OF CONTENTS ACKNOWLEDGEMENTS .......................................................................................... ii ABSTRACT ................................................................................................................. -
18 Rapid Disinfection of Combined Sewer Overflow Using Chlorine Dioxide
18 Rapid Disinfection of Combined Sewer Overflow Using Chlorine Dioxide R. Takahashi1 , T.Kirihara2 , M.Koeda3 1 Director, 2 Chief Researcher, 3 Senior Researcher Japan Institute of Wastewater Engineering Technology ABSTRACT This is a technology in which disinfection of untreated sewage from pump stations in combined sewer systems and primary effluent from final treatment plants is performed by oxidization using chlorine dioxide. As a distinctive feature of the technology, the disinfectant is rapidly and uniformly injected and diffused in the water channel cross-section, resulting in substantially improved disinfection efficiency in comparison with conventional methods using chlorine disinfectants such as sodium chlorite. KEYWORDS Disinfection, chlorine dioxide, ClO2 generation system, ClO2 injection system 1. OUTLINE OF TECHNOLOGY 1.1 Principle of technology Chlorine dioxide is expressed by the chemical formula ClO2, and is a reddish-yellow gas with a pungent odor resembling chlorine or ozone at room temperature. Its physical constants are shown in Table 1. Chlorine oxide is water soluble and exists in aqueous solutions in the form of ClO2. Because it is strongly oxidizing and has the following distinctive properties, it is considered suitable for use as a disinfectant in combined sewers: 1) Rapid disinfection effect in comparison with chlorine agents (sodium hypochlorite, etc.), 2) In the range of pH 6-10, the effect of pH on disinfection effectiveness is not as great as with chlorine, 3) Does not react with ammonia, 4) Does not form tri-halide-methane, and 5) Does not display persistence, and therefore has little adverse effect on public waters. Furthermore, contact with coliform groups is achieved within a short time as a result of rapid and uniform injection/diffusion of ClO2 in the water channel cross-section. -
Chlorine Dioxide Incident Management
Chlorine Dioxide Incident Management Key Points Fire not combustible, but enhances combustion of other substances oxidising agent reacts violently with organics, phosphorus, potassium hydroxide and sulphur, causing a fire and explosion hazard emits toxic fumes of chlorine when heated to decomposition; reacts with water to produce hydrochloric acid and chloric acid Health major routes of exposure are inhalation or ocular inhalation causes irritation of eyes and nose with sore throat, cough, chest tightness, headache, fever, wheeze, tachycardia and confusion chemical pneumonitis, tachypnoea, dyspnoea and stridor due to laryngeal oedema may follow inhalation exposure corrosive damage to respiratory tract occurs in serious cases; severe injuries may result in persistent hoarseness, pulmonary fibrosis and chronic obstructive airway disease Environment hazardous to the environment; inform the Environment Agency of substantial incidents PHE publications gateway number: 2014790 Published: January 2016 Compendium of Chemical Hazards: Chlorine Dioxide Hazard Identification Standard (UK) dangerous goods emergency action codes Data not available Classification, labelling and packaging (CLP)* Chlorine dioxide (in aqueous solution) Hazard class and Acute Tox. 3 Acute toxicity (oral), category 3 category Skin Corr. 1B Skin corrosion, category 1B Aquatic Acute 1 Acute hazards to the aquatic environment, category 1 Hazard statement H301 Toxic if swallowed H314 Causes severe skin burns and eye damage H400 Very toxic to aquatic life Signal words DANGER * Implemented in the EU on 20 January 2009 Reference European Commission. Harmonised classification – Annexe VI to Regulation (EC) No. 1272/2008 on Classification, Labelling and Packaging of Substances and Mixtures. http://echa.europa.eu/information-on-chemicals/cl-inventory- database (accessed 07/2015). -
Lysosomal Cystine Transport in Cystinosis Variants and Their Parents
0031-3998/87/2102-0193$02.00/0 PEDIATRIC RESEARCH Vol. 21, No.2, 1987 Copyright© 1987 International Pediatric Research Foundation, Inc. Primed in U.S.A. Lysosomal Cystine Transport in Cystinosis Variants and their Parents WILLIAM A. GAHL AND FRANK TIETZE Section on Human Biochemical Genetics, Human Genetics Branch, NJCHD and Laboratory of Molecular and Cellular Biology, NJDDKD, National Institutes of Health, Bethesda, Maryland 20892 ABSTRACT. Children with nephropathic cystinosis store niques were applied to cells from patients with intermediate and 50 to 100 times normal amounts of free cystine in many benign cystinosis. cells and display negligible lysosomal cystine transport in their leucocytes and cultured fibroblasts. A patient with CASE REPORTS intermediate (adolescent) cystinosis exhibited a similar deficiency of egress out of fibroblast lysosome-rich granu Patient 1. This boy, patient 2 of a previous report (12), was lar fractions. Another individual with benign (adult) cysti noted to have corneal opacities at age 5 yr, when growth, urinal 2 nosis accumulated only 2.85 nmol1/2 cystine/mg leucocyte ysis, and creatinine clearance (105 ml/min/1.73 m ) were nor protein, or 20-50% of the amount stored in nephropathic mal. By age 13 yr, serum creatinine was 2.2 mg/dl and 24-hr cystinosis leucocytes. His leucocyte granular fractions also urine protein excretion was 3.0 g, prompting a change in the displayed substantial residual cystine-carrying capacity, as original diagnosis from benign to intermediate cystinosis. A renal determined by measurement of lysosomal cystine counter allograft was performed at age 14 yr. The patient's leucocyte transport. -
5.01.612 Pharmacologic Treatment of Cystinosis
PHARMACY POLICY – 5.01.612 Pharmacologic Treatment of Cystinosis Effective Date: Oct. 1, 2020 RELATED MEDICAL POLICIES: Last Revised: Sept. 17, 2020 None Replaces: N/A Select a hyperlink below to be directed to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | CODING RELATED INFORMATION | EVIDENCE REVIEW | REFERENCES | HISTORY ∞ Clicking this icon returns you to the hyperlinks menu above. Introduction Cystinosis is a rare, inherited disease that is caused by a change (mutation) in the CTNS gene. The CTNS gene provides instructions to help move an amino acid called cystine out of cells and into other areas of the body, like the digestive system, immune system, skeletal system, skin, and hair. Cystinosis occurs when cystine doesn’t move out of cells and instead builds up and forms crystals that cause cell death. Cystinosis slowly damages and destroys organs, including the kidneys, liver, eyes, muscles, and brain. The kidneys and the eyes are the organs that are most affected. Three types of cystinosis exist based on the age of onset and how severe the symptoms are: nephropathic (infancy), late-onset (teens to adults), and ocular, or “benign” (adults). Treatment of cystinosis is meant to remove cystine from the cells and delay any further damage to organs in the body. This policy describes when drugs used to treat cystinosis may be considered medically necessary. Note: The Introduction section is for your general knowledge and is not to be taken as policy coverage criteria. The rest of the policy uses specific words and concepts familiar to medical professionals. It is intended for providers. A provider can be a person, such as a doctor, nurse, psychologist, or dentist. -
New Agent in the Treatment of Cystinuria: N-Acetyl-D-Penicillamine
BrJRNA 284 3 February 1968 MEDCAL JOURNAL Br Med J: first published as 10.1136/bmj.1.5587.284 on 3 February 1968. Downloaded from New Agent in the Treatment of Cystinuria: N-acetyl-D-penicillamine G. S. STOKES,* M.D., B.S.; J. T. POTTS, jun.,t M.D.; M. LOTZ,4 M.D.; F. C. BARTTER,§ M.D. Brit. med. Y., 1968, 1, 284-288 Treatment of cystinuria with D-penicille, introduced by D-penicillamine 2 g./day. During a drug-free control period Crawhall, Scowen, and Watts (1963), has dramatically reduced of 6 to 12 days routine haematological, renal, and hepatic morbidity due to cystine urolithiasis in selected patients, both function tests were carried out, two or more 24-hour urine by preventing new stone formation (Crawhall, Scowen, and collections were analysed for cystine, and serum copper and Watts, 1964; Bartter, Lotz, Thier, Rosenberg, and Potts, 1965; ceruloplasmin were determined; in one patient urinary iron MacDonald and Fellers, 1966) and by dissolving stones lodged and copper excretion were estimated by the methods of Gubler, in the renal pelvis (Lotz and Bartter, 1965; McDonald and Lahey, Ashenbrucker, Cartwright, and Wintrobe (1952) and Henneman, 1965). These effects were apparently based on Henry, Sobel, and Chiamori (1958), respectively. In six formation of the more soluble mixed disulphide, penicillamine- patients urinary excretion of kynurenine during 24 hours after cysteine, in place of cystine. However, the administration of a 2-g. oral load of L-tryptophan was determined by the method D-penicillamine involves a definite risk of complications, such of Tompsett (1959). -
Supplemental Canine Cystine Information
Minnesota Urolith Center UNIVERSITY OF MINNESOTA College of Veterinary Medicine 1352 Boyd Avenue St Paul, MN 55108 Urolithcenter.org Phone 612.625.4221 Fax 612.626.3226 email [email protected] Common Questions on Dogs Forming Cystine Stones 10/2019 How will I know if my dog has cystinuria? 1. Cystine is an amino acid that is freely filtered in urine and almost completely reabsorbed by the kidney tubules (i.e. removed from the urine). 2. As urine cystine concentration increases, a positive urine nitroprusside test, cystine crystals and cystine stones are indicators of disease. 3. Although cystinuria and cystine crystalluria do not cause clinical signs, cystine stones can irritate the lining of the urinary tract resulting in urinary accidents, urgency, straining, or bloody urine. In some cases, the stones result in life-threatening urinary obstruction. Cystine stones are not always visible on x-rays and may require special contrast studies or an ultrasound to diagnosis. 4. Genetic tests for cystinuria are available for some breeds of dogs. A genetic marker test for androgen dependent cystinuria has been developed for Mastiffs, English bulldogs and French bulldogs. There are other breeds with androgen dependent cystinuria as well as other breeds in which castration will not reduce cystinuria (Type Ia, reported in Newfoundland dogs, Labradors and Landseers,Type IIa, reported in Australian Cattle dogs and Border Collies, Type IIb, reported in Miniature Pinschers). Will castration prevent recurrence of cystine stones? 1. Surgical or medical castration can resolve/cure cystinuria in the subset of male dogs with androgen dependent cystinuria. 2. The magnitude of cystinuria associated with stone formation is wide (100 to >10,000 ɥmol/g creatinine) and varies between serial measurements in the same dog. -
Appendix 3-3 Ignition / Explosion Risk Caused by Blending [Safety Guidelines for Chemical Experiments, 4Th Edition] by the Chemical Society of Japan, Maruzen (1999)
Supplement 1. Safe Handling of Hazardous Substances Appendix 3-3 Ignition / Explosion Risk Caused by Blending [Safety Guidelines for Chemical Experiments, 4th Edition] by the Chemical Society of Japan, Maruzen (1999) This table has been classified and structured according to the chemical structure based on the NFPA’s (National Fire Protection Association) “Manual of Hazardous Chemical Reaction 491M (1975),” in which examples of accident cases and hazardous reaction cases involving chemical substances blending have been compiled. 1. Oxidizing Substance & Flammable Substance 1) Oxidizing Substance 2) Flammable Substance a) oxo-halogen acid salt a) non-metal elemental substance perchlorate, chlorate, bromate, iodate, chlorite, phosphorus, sulfur, activated carbon, etc. hypochlorite, etc. b) metallic peroxide, hydrogen peroxide b) metal metallic peroxide: potassium peroxide, calcium magnesium, zinc, aluminum, etc. peroxide, etc. c) permanganate c) sulfide potassium permanganate, etc. phosphorus sulfide, antimony sulfide, carbon bisulfide, etc. d) nichrome acid salt d) hydride dichromate potassium, etc. silane, phosphine, dibrane, arsine, etc. e) nitrate salt e) carbide potassium nitrate, sodium nitrate, ammonium calcium carbide nitrate, etc. f) nitric acid, fuming nitric acid f) organic substance hydrocarbon, alcohol, ketone, organic acid, amine, etc. g) nitric acid, fuming nitric acid, chlorosulfuric g) other acid metal amid, cyanide, hydroxylamine, etc. h) chrome oxide (III) i) perchloric acid j) peroxodisulfuric acid k) chlorine oxide, chlorine dioxide, chlorine monoxide l) nitrogen dioxide (nitrogen tetroxide) m) halogen fluorine, chlorine, bromine, iodine, chlorine trifluoride, bromine trifluoride, iodine trifluoride, chlorine pentafluoride, bromine pentafluoride, iodine pentafluoride n) halogenation nitrogen nitrogen trifluoride, nitrogen trichloride, nitrogen tribromide, nitrogen triiodide 2. Hydrogen Peroxide & Metallic Oxide 3. Persulfate & Manganese metallic oxide managanese dioxide, mercuric oxide 4.